雷丸菌丝蛋白对H_(22)荷瘤小鼠的肿瘤抑制及免疫调节作用  被引量:9

Effect of Proteins Extracted from Mycelia of Omphalia lapidescens on Inhibiting H_(22) Liver Cancer in Mice and Regulating Immune Function

在线阅读下载全文

作  者:陈宜涛[1] 林美爱[2] 程东庆[1] 石志坚[1] 朱健灵[1] 吴剑[1] 

机构地区:[1]浙江中医药大学生命科学学院,浙江杭州310053 [2]浙江中医药大学研究生处,浙江杭州310053

出  处:《中药材》2009年第12期1870-1874,共5页Journal of Chinese Medicinal Materials

基  金:浙江省自然科学基金项目(Y207765);浙江省教育厅科研项目(20050817);浙江省中医药科技计划项目(2007YA005)

摘  要:目的:提取雷丸菌丝蛋白,检测其对H_(22)肝癌细胞荷瘤小鼠的肿瘤抑制作用。方法:随机将50只ICR小鼠分为5组,分别为模型组、环磷酰胺组及雷丸菌丝蛋白高(5 mg/kg)、中(3 mg/kg)、低(1 mg/kg)剂量组,尾静脉给药,1次/d,共8 d。停药次日取血后处死小鼠,计算抑瘤率,以酶联免疫法测定小鼠血清IL-4和IFN-y含量。结果:雷丸菌丝蛋白高、中、低剂量均能有效抑制肿瘤的生长(P<0.05)。高剂量抑制率达36.4%,但低于环磷酰胺43.2%的肿瘤抑制率。雷丸菌丝蛋白在抑制肿瘤生长的同时,能够增加小鼠血清IFN-γ含量,降低血清IL-4含量,并能提高脾脏指数。但对小鼠胸腺、肝脏、心脏、肺脏和肾脏指数无明显影响。结论:雷丸菌丝蛋白对H_(22)肝癌细胞所致实体瘤具有显著抑制作用,并能在一定程度上增强小鼠免疫功能。Objective:To explore the effect of proteins extraceed from mycelia of Omphalia lapidescens on inhibiting H22 liver cancer in vivo.Methods:50 hepatoma 22 tumor bearing mice models were divided into five groups randomly:control group(CG),cyclophosphamide group,and 3 groups of incremental Hepatoma 22 dosages(5,3,1 mg/kg).All groups were i.v.with drugs once a day.After 8 consecutive days,the concentrations of interferon-γ(IFN-γ) and interleukin-4(IL-4) in serum were detected by enzyme-linked immunoabsorbent assay(ELISA).The weight changes of tumor,thymus,liver,heart,spleen,lung and kidney were observed.Results:It showed the tumors' weight were significant heavier in CG than in EGs.The tumor-inhibition rate(IR) was 36.4%in high dosage group,which was lower than 43.2%in cyclophosphamide group.The spleen mass of proteins groups increased significantly.The concentration of IFN-γin serum of proteins groups increased as CG,but IL-4 in inverse direction.The observations of thymus,liver,heart, lung and kidney in EGs were the same as CG.Conclusion:The proteins extracted from mycelium of Omphalia lapidescens can inhibit the growth of tumour and enhance the immune function of H22 tumor-bearing mice.

关 键 词:药用真菌 细胞因子 液体发酵 中药 

分 类 号:R285.5[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象